Karanta mu | Saurara mana | Kalli mu | Join Abubuwan Live | Kashe Talla | Live |

Latsa yarenku don fassara wannan labarin:

Afrikaans Afrikaans Albanian Albanian Amharic Amharic Arabic Arabic Armenian Armenian Azerbaijani Azerbaijani Basque Basque Belarusian Belarusian Bengali Bengali Bosnian Bosnian Bulgarian Bulgarian Catalan Catalan Cebuano Cebuano Chichewa Chichewa Chinese (Simplified) Chinese (Simplified) Chinese (Traditional) Chinese (Traditional) Corsican Corsican Croatian Croatian Czech Czech Danish Danish Dutch Dutch English English Esperanto Esperanto Estonian Estonian Filipino Filipino Finnish Finnish French French Frisian Frisian Galician Galician Georgian Georgian German German Greek Greek Gujarati Gujarati Haitian Creole Haitian Creole Hausa Hausa Hawaiian Hawaiian Hebrew Hebrew Hindi Hindi Hmong Hmong Hungarian Hungarian Icelandic Icelandic Igbo Igbo Indonesian Indonesian Irish Irish Italian Italian Japanese Japanese Javanese Javanese Kannada Kannada Kazakh Kazakh Khmer Khmer Korean Korean Kurdish (Kurmanji) Kurdish (Kurmanji) Kyrgyz Kyrgyz Lao Lao Latin Latin Latvian Latvian Lithuanian Lithuanian Luxembourgish Luxembourgish Macedonian Macedonian Malagasy Malagasy Malay Malay Malayalam Malayalam Maltese Maltese Maori Maori Marathi Marathi Mongolian Mongolian Myanmar (Burmese) Myanmar (Burmese) Nepali Nepali Norwegian Norwegian Pashto Pashto Persian Persian Polish Polish Portuguese Portuguese Punjabi Punjabi Romanian Romanian Russian Russian Samoan Samoan Scottish Gaelic Scottish Gaelic Serbian Serbian Sesotho Sesotho Shona Shona Sindhi Sindhi Sinhala Sinhala Slovak Slovak Slovenian Slovenian Somali Somali Spanish Spanish Sudanese Sudanese Swahili Swahili Swedish Swedish Tajik Tajik Tamil Tamil Telugu Telugu Thai Thai Turkish Turkish Ukrainian Ukrainian Urdu Urdu Uzbek Uzbek Vietnamese Vietnamese Welsh Welsh Xhosa Xhosa Yiddish Yiddish Yoruba Yoruba Zulu Zulu

Gwajin allurar rigakafi na 3 a cikin UAE da Rasha suna da alkawarin

Gwajin allurar rigakafi na 3 a cikin UAE da Rasha yayi alƙawari
alurar riga kafi

Kamfanin harhada magunguna na kasar Sin Sinopharm ya fara gwajin kashi na III na maganin COVID-19 a Abu Dhabi ta amfani da masu sa kai 15,000, in ji gwamnati a babban birnin Hadaddiyar Daular Larabawa a ranar Alhamis.

Ofishin watsa labarai na gwamnatin Abu Dhabi a ranar Alhamis din nan ya ce ana gwajin kashi uku-uku na gwaji na yiwuwar samar da rigakafin COVID-19 a masarautar, babban birnin Hadaddiyar Daular Larabawa. Gwajin ɗan adam shine farkon gwaji na uku na WHO don jerin allurar rigakafi.

Gwajin na hadin gwiwa tsakanin kamfanin hada magunguna na kasar Sin Sinopharm na China National Biotec Group (CNBG), da Abu Dhabi da ke aikin leken asiri, da kamfanin hada hadar girgije Group 42 (G42) da kuma Ma'aikatar Lafiya ta Abu Dhabi, a cewar kamfanin dillancin labarai na Reuters.

Sheikh Abdullah bin Mohammed Al Hamed, shugaban Sashin Kiwon Lafiya na Abu Dhabi, shi ne farkon wanda ya shiga cikin shari’ar. Kimanin masu aikin sa kai 15,000 na tsawon watanni uku zuwa shida za a dauka.

Gwajin ɗan adam haɗin gwiwa ne tsakanin Sinopharm's China National Biotec Group (CNBG), kamfanin Abu Dhabi mai ƙididdigar kere-kere da kamfanin hada-hadar girgije Group 42 (G42) da Sashin Kiwon Lafiya na Abu Dhabi.

Binciken, wanda aka fara a ranar Laraba, shi ne gwaji na Farko na uku a duniya game da allurar rigakafin da ba ta aiki, in ji Shugaban Asusun Kula da Lafiya na G42 Ashish Koshy. Alurar riga kafi sanannu sanannu kuma anyi amfani dasu akan cututtuka kamar mura da kyanda.

Babu wani maganin rigakafin COVID-19 wanda har yanzu ba a yarda dashi don amfanin kasuwanci ba. Dangane da taƙaitaccen rahoton WHO game da yanayin ci gaba da rigakafin cutar ga COVID-19, akwai alluran rigakafi 23 a cikin gwajin ɗan adam, tare da uku daga cikinsu a cikin ko fara babban matakin ƙarshen matakin, ko Phase III, gwaji don gwada inganci.

Gwajin zai gwada nau'ikan allurar rigakafi biyu da kuma placebo. Za a gudanar da allurai biyu makonni uku tsakani kuma za a bi masu sa kai na tsawon shekara guda, in ji Nawal Alkaabi, shugaban Kwamitin Gudanar da Clinical na COVID-19 na UAE.

Kimanin masu aikin sa kai 15,000 sama da watanni uku zuwa shida za a tattara su, da farko a Abu Dhabi. Za su kasance shekaru 18 zuwa 60 ba tare da wata matsala mai mahimmanci ba game da kiwon lafiya kuma ba tare da kamuwa da COVID-19 ba a baya, in ji Alkaabi.

Sinopharm ya zaɓi Hadaddiyar Daular Larabawa ne saboda kusan ƙasashe 200 daban-daban suna zaune a can kuma yana mai da hankali kan binciken likita da yaƙi da cutar, in ji Koshy.

Hadaddiyar Daular Larabawa ta ce ta gudanar da gwaje-gwaje fiye da miliyan 4 na kwayar cutar kanjamau a kan kusan mutane miliyan 9.6. Ya rubuta kusan mutane dubu 56,000 na kamuwa da cutar da kuma mutuwar mutane 335.

Kashi na biyu na gwajin allurar rigakafin COVID-19 a Rasha ana sa ran kammala shi a ranar 3 ga watan Agusta, shugaban Asusun Rayayyar Zuba Jari na Rasha Kirill Dmitriev ya fada a ranar Alhamis.

Dama bayan an fara kashi na uku, za a yi shi ne "ba kawai a Rasha ba har ma a Gabas ta Tsakiya da wasu sauran kasashe," in ji Dmitriev.

Rasha ta ci gaba da kirkirar alluran rigakafi 26, kuma daya daga cikin su, wanda Cibiyar Bincike ta Kasa da Kasa ta Gamaleya da Microbiology ta samar, ta yi nasarar fuskantar matakin farko na gwaji.

Wani maganin rigakafin daga kafa cibiyar bincike, Cibiyar Kimiyyar Jiha "Vector", ana binciken masana don samun izinin gwaji na asibiti.

Da aka tambaye shi game da gasa wajen samar da allurar rigakafin cutar ta COVID-19, shugaban Cibiyar Gamaleya Alexandr Ginzburg ya ce: "Duniya na bukatar allurar rigakafin da ba a taba samu ba", ma'ana dukkan masu kera za su sami wadatattun abokan ciniki.

Mutanen da suka tsira daga mummunar cutar coronavirus ba sa buƙatar yin rigakafi game da ƙwayar ƙwayar ƙwayar cuta yayin da suke ci gaba da ba da amsa mai ƙarfi, in ji shi.

Ya kuma ba da shawarar yin hutun aƙalla makonni biyu tsakanin yin allurar rigakafin COVID-19 da sauran cututtuka.

A halin yanzu, Ma'aikatar Masana'antu da Ciniki ta Rasha na shirye-shiryen fara fara samar da allurar rigakafin da zaran an kammala gwajin asibiti kuma hukumomin lafiya sun amince da shi, in ji shugabanta Denis Manturov.

A cewar Manturov, masana'antar ta sake bayyana karfin ta don fadada samar da hanyoyin da ake bukata don magance yaduwar cutar, gami da gwaje-gwaje masu sauri, magunguna kan cutar nimoniya mai tsanani, da maganin anti-COVID na Favipiravir.

#tasuwa